Michael Porubcin, M.D.

Phone Number:

(309) 779-4265




Comenius University, Slovak Republic - Medical School

Memorial Sloan Kettering Cancer Center - Cell Biology & Genetics and Molecular Pharmacology & Chemistry Program

University of South Alabama - Internal Medicine Residency, Hematology/Oncology Fellowship

MD Anderson Cancer Center - Department of Stem Cell Transplantation & Cellular Therapy


Board Certified in Hematology

Board Certified in Medical Oncology


American Society of Clinical Oncology (ASCO)

American Society of Hematology (ASH)

Catholic Medical Association (CMA)


Laboratory Director - Medical Arts Associates, Ltd. (2000-Present)

Medical Director - Oncology Services, UnityPoint Health-Quad Cities (2015 - 2017)

Hospital Affiliations:

Unity Point Health - Trinity Rock Island, Moline and Bettendorf Campus

Genesis Medical Center Illini Campus

Clinical Research Affiliations:

Cancer Trials Support Unit (CTSU)

Outside Interests:

Spending time with family and friends. Love reading and playing tennis.


1. Garrick MD, Dolan KG, Horbinski C, Ghio AJ, Higgins D, Porubcin M, Moore EG, Hainsworth LN, Umbreit JN, Conrad ME, Feng L, Lis A, Roth JA, Singleton S, Garrick LM: DMT1: a mammalian transporter for multiple metals. Biometals, Review, 2003 March; 16(1): 41-54.

2. Marcel E. Conrad, Jay N. Umbreit, Elizabeth G. Moore, Lucille N. Hainsworth, Michael Porubcin, Marcia J. Simovich, Marian T. Nakada, Kevin Dolan, and Michael D. Garrick: Separate pathways for cellular uptake of ferric and ferrous iron. Am J Gastrointest Liver Physiol 2000 Oct; 279 (4):G767-74.

3. Otrusinik R, Alpert MA, Hamm CR, Bikkina M, Porubcin M, Panayiotou H: Factors predicting coronary artery disease in patients with giant negative T waves. Am J Cardiol. 2000 April 1; 85(7):873-5, A9.

4. Ross RA, Spengler BA, Domenech C, Porubcin M, Rettig WJ, and Biedler JL (1994): Human Neuroblastoma I-Type Cells are Malignant Neural Crest Stem Cells. Cell Growth Differ April 1995; 6(4):449-56.

5. Spengler BA, Domenech C, Porubcin M, Biedler JL: Human Neuroblastoma Lines Respond Differently to Diverse Differentiation-Inducing Agents. In Evans AE, Biedler JL, Brodeur GM, D'Angio GJ, and Nakagawara A (eds): "Advances in Neuroblastoma Research 4. New York: Wiley-Liss, Inc., 1994; pp 261-267.

6. Biedler JL, Chang TD, Druskin H, Meyers MB, Porubcin M, Spengler BA: Rapid Elimination of P-glycoprotein-encoding Genes After Exposure of Vincristine-resistant Chinese Hamster Lunc Gells, DC-3F/VCR-5L, to Verapamil. Gen. Motors Cancer Res. Found. Int. Symp., Toronto, Canada, May 6-8, 1993.

7. Chang YM, Aschele CS, Porubcin M, Bertino JR: Sensitivity of Two Fluorouracil Resistant HCT-8 cell Lines to Fluorouridine (FUR), Methotrexate (MTX) and D1694, a Folate Inhibitor of Thymidylate Synthase. Proc. Amer. Cancer Res. 33:543, 1992.